|
Orthologous residues
|
|
SSH1 (human): S978‑p, SSH1 iso2 (human): ‑, SSH1 iso4 (human): S666‑p, SSH1 (mouse): S970‑p, SSH1 (rat): S932‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial), COS (fibroblast), MCF-7 (breast cell)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human, monkey
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
neuregulin
|
|
|
|
decrease
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
inhibition, intracellular localization, molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
14-3-3 beta (human)
|
|
Induces
|
|
|
in vitro
|
|